지혈 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global hemostasis market size is expected to reach USD 4.21 Billion in 2034 from USD 2.45 Billion in 2025, growing at a CAGR of 6.21 during 2026-2034.This market is witnessing significant growth due to the increasing prevalence of surgical procedures, traumatic injuries, and chronic medical conditions requiring effective bleeding management. Healthcare providers are adopting advanced hemostatic products to improve patient outcomes, reduce surgical complications, and shorten recovery periods. Rising healthcare expenditure and continuous improvements in medical technologies are supporting the growing demand for innovative hemostasis solutions across hospitals and surgical centers.

Growing numbers of cardiovascular surgeries, orthopedic procedures, and minimally invasive operations are driving product adoption worldwide. Manufacturers are introducing advanced hemostatic agents, sealants, and biologically derived products that provide faster bleeding control and improved clinical performance. Increasing investments in healthcare infrastructure and expanding access to modern surgical care are creating additional opportunities for companies operating within this industry.

The future outlook remains favorable as technological innovation continues improving product safety, effectiveness, and ease of use. Rising demand for advanced surgical procedures, expanding aging populations, and increasing focus on patient safety will sustain long-term market growth. Ongoing research in regenerative medicine and bioengineered hemostatic materials is expected to introduce next-generation products that further strengthen industry expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Topical Hemostasis (Collagen, ORC, Gelatin, Polysaccharides)
• Infusible Hemostasis (FFP, Platelet Conc, Factor VIII, PCC)
• Advanced Hemostasis (Flowable, Thrombin, Fibrin, Synthetic)

By Formulation

• Matrix & Gel
• Sponge & Pad
• Powder
• Liquid / Spray

By Application

• Trauma
• Surgery
• Hemophilia
• Myocardial Infarction
• Thrombosis
• Others

By End User

• Hospitals
• Clinics & ASCs
• Others

COMPANIES PROFILED

• CSL Behring, Grifols S.A., Johnson & Johnson (Ethicon), Tricol Biomedical, CryoLife Inc. (Artivion), Integra LifeSciences Holdings Corporation, Marine Polymer Technologies Inc., KitoTech Medical, Arch Biomedical

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEMOSTASIS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Topical Hemostasis (Collagen, ORC, Gelatin, Polysaccharides) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Infusible Hemostasis (FFP, Platelet Conc, Factor VIII, PCC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Advanced Hemostasis (Flowable, Thrombin, Fibrin, Synthetic) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HEMOSTASIS MARKET: BY FORMULATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Formulation
• 5.2. Matrix & Gel Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Sponge & Pad Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Powder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Liquid / Spray Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HEMOSTASIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Trauma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hemophilia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Myocardial Infarction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Thrombosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HEMOSTASIS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinics & ASCs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL HEMOSTASIS MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Formulation
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Formulation
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Formulation
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Formulation
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Formulation
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL HEMOSTASIS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 CSL Behring
  • 10.2.2 Grifols S.A
  • 10.2.3 Johnson & Johnson (Ethicon)
  • 10.2.4 Tricol Biomedical
  • 10.2.5 CryoLife Inc. (Artivion)
  • 10.2.6 Integra LifeSciences Holdings Corporation
  • 10.2.7 Marine Polymer Technologies Inc
  • 10.2.8 KitoTech Medical
  • 10.2.9 Arch Biomedical